Drug · DIN 02559935
ELTROXIN
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since July 31, 2025.
- Drug Identification Number (DIN)
- 02559935
- Company (DIN owner)
- Aspen Pharmacare Canada Inc.Oakville, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Levothyroxine sodium H03AA01
- Class
- Human
- Record last updated
- September 3, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| LEVOTHYROXINE SODIUM | 88 MCG |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 31, 2025: NOC 35815Supplement to a New Drug Submission (SNDS) · Addition of new strength: 25mcg, 75mcg, 88mcg, 112mcg, 125mcg, 137mcg, and 175mcg Tablets
Other DINs named ELTROXIN
- DIN 02213192 · Marketed
- DIN 02213206 · Marketed
- DIN 02213214 · Marketed
- DIN 02213222 · Marketed
- DIN 02213230 · Cancelled Post Market
- DIN 02559919 · Approved
- DIN 02559927 · Approved
- DIN 02559943 · Approved
- DIN 02559951 · Approved
- DIN 02559978 · Approved
- DIN 02559986 · Approved